section name header

Use and Dosing

Adult Dosingnavigator.gif

Moderate-severe rheumatoid arthritis

IV infusion

SC injection

Pediatric Dosingnavigator.gif

Polyarticular Juvenile Idiopathic Arthritis

Systemic Juvenile Idiopathic Arthritis

Note:


[Outline]

Indications

Contraindications

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment (Based on CrCl)

Hepatic Dose Adjustment

Warnings/Precautions

See Supplemental Patient Information

Cautions: Use cautiously in

Supplemental Patient Information

Pregnancy/Breast Feeding

Pregnancy Category:C

Breastfeeding: Safety unknown; due to the potential for serious adverse reactions in nursing infants, manufacturer recommends discontinuation of nursing or discontinuation of drug, taking into account the importance of the drug to the mother.

Adverse Reactions

Clinical Pharmacology

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

Actemra

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

Actemra

flag_uk32.png

UK Trade Name(s)

UK Availability

RoActemra

flag_australia32.png

Australian Trade Name(s)

Australian Availability

Actemra


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Rheumatologic

Immunomodulator
Disease-modifying Antirheumatic Agents